镰状细胞性状难治性血尿的医学管理

Medical management of refractory hematuria in sickle-cell trait.

作者信息

Meyersfield S A, Morganstern S L, Seery W, Cole A T

出版信息

Urology. 1976 Aug;8(2):112-3. doi: 10.1016/0090-4295(76)90333-2.

Abstract

Hematuria secondary to sickle-cell trait has on occasion proved refractory to medical management. We have adopted a new six-drug regimen to deal with this difficult problem. Herein is reported our experience with this protocol in 2 patients. Our results have been excellent, with hematuria clearing within twenty-four hours. The drug regimen is used in an attempt to alter the conditions that are favorable for sickling in the renal medulla.

摘要

镰状细胞性状继发的血尿有时经药物治疗难以控制。我们采用了一种新的六药联合方案来处理这一难题。本文报告了我们对2例患者应用该方案的经验。我们的结果非常好，血尿在24小时内消失。该药物方案旨在改变有利于肾髓质镰状化的条件。